- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有22家主力机构披露2025-06-30报告期持股数据，持仓量总计1.33亿股，占流通A股53.23%
- 波段诊断：
-
技术面诊股
诊断结果：5.0技术面打败了51%的股票
技术面评分前10的股票
近期的平均成本为20.35元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为20.35元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"20.35","date":1765180871,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2025.12.09","stock":"-1.22","trade":"-1.51","ind":"-0.39"},{"date":"2025.12.08","stock":"0.00","trade":"0.25","ind":"1.39"},{"date":"2025.12.05","stock":"0.49","trade":"0.10","ind":"1.08"},{"date":"2025.12.04","stock":"-0.83","trade":"-0.40","ind":"0.40"},{"date":"2025.12.03","stock":"-0.05","trade":"-0.45","ind":"-0.78"},{"date":"2025.12.02","stock":"-1.11","trade":"-1.08","ind":"-0.68"},{"date":"2025.12.01","stock":"0.63","trade":"0.07","ind":"1.25"},{"date":"2025.11.28","stock":"0.44","trade":"-0.17","ind":"0.85"},{"date":"2025.11.27","stock":"-0.63","trade":"-0.20","ind":"-0.25"},{"date":"2025.11.26","stock":"0.39","trade":"1.10","ind":"1.02"},{"date":"2025.11.25","stock":"0.88","trade":"2.23","ind":"1.53"},{"date":"2025.11.24","stock":"0.44","trade":"1.45","ind":"0.37"},{"date":"2025.11.21","stock":"-3.56","trade":"-3.83","ind":"-3.41"},{"date":"2025.11.20","stock":"-0.52","trade":"-0.26","ind":"-0.76"},{"date":"2025.11.19","stock":"-1.03","trade":"-1.93","ind":"-0.00"},{"date":"2025.11.18","stock":"-0.70","trade":"-1.16","ind":"-0.92"},{"date":"2025.11.17","stock":"-1.87","trade":"-1.58","ind":"-0.11"},{"date":"2025.11.14","stock":"-0.05","trade":"0.97","ind":"-1.93"},{"date":"2025.11.13","stock":"0.55","trade":"1.58","ind":"1.78"},{"date":"2025.11.12","stock":"-0.32","trade":"0.46","ind":"-0.36"},{"date":"2025.11.11","stock":"-0.36","trade":"0.64","ind":"-1.03"}]
力生制药,深证成指,化学制药指数
压力支撑
该股压力位为20.30元，支撑位为20.07元。
[{"text":"\u538b\u529b\u4f4d","value":"20.30","date":1765209600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"20.07","date":1765209600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.2资金面打败了51%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：12月09日 17:33
| 机构今日流向(万元) | -2193.04 | 机构5日流向(万元) | -5025.89 |
| 机构10日流向(万元) | -10543.60 | 机构20日流向(万元) | -19454.58 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少156.6万股，其中基金净减仓7家，主力净减仓9家，请投资者中长期谨慎为宜。
截止2025-06-30，共22家主力机构（基金20家，一般法人2家），持仓量总计13324.42万股，占流通A股53.23%
其中，基金持仓与2024-12-31相比：
增仓：1家 ，增持 0.05万股
减仓：8家 ，减持 20.46万股
新出现在主力名单中：10家 ，持有5.5万股
从主力名单中消失：19家 ，原持有141.69万股
其中，基金持仓与2024-12-31相比：
增仓：1家 ，增持 0.05万股
减仓：8家 ，减持 20.46万股
新出现在主力名单中：10家 ，持有5.5万股
从主力名单中消失：19家 ，原持有141.69万股
消息面诊股
诊断结果：5.5消息面打败了17%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 力生制药：12月8日获融资买入554.07万元
2025-12-09 - 力生制药闪耀第19届成长型医药企业发展大会
2025-12-08 - 力生制药：12月5日获融资买入431.46万元
2025-12-08 - 力生制药召开营销团队启航大会 凝聚共识谋发展 深耕
2025-12-05 - 力生制药：12月4日获融资买入594.90万元
2025-12-05 - 力生制药携手紫光软件 开启档案管理数字化转型新篇章
2025-12-04 - 力生制药：目前并未放弃国鑫泰达股权投资基金投资计划
2025-12-04 - 力生制药：12月3日获融资买入745.04万元
2025-12-04 - 力生制药多维发力，闪耀第19届成长型医药企业发展大
2025-12-03 - 力生制药举办“合成生物绿色制造生物基产品专题培训”
2025-12-03
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-10-24 |
| 一般消息 | 重大事项 | 关联交易 | 2025-09-09 |
| 一般消息 | 高管变动 | 公司取消监事会 | 2025-09-08 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-22 |
| 一般消息 | 募资投向 | 2025-08-22 | |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-07-15 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-12 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-04-01 |
| 利好 | 分红转增 | 10派3.5元(含税) | 2025-03-21 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-21 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 1条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.7行业面打败了73%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.12.09","price":"-0.39","value":"-1.51"},{"date":"2025.12.08","price":"1.39","value":"0.25"},{"date":"2025.12.05","price":"1.08","value":"0.10"},{"date":"2025.12.04","price":"0.40","value":"-0.40"},{"date":"2025.12.03","price":"-0.78","value":"-0.45"},{"date":"2025.12.02","price":"-0.68","value":"-1.08"},{"date":"2025.12.01","price":"1.25","value":"0.07"},{"date":"2025.11.28","price":"0.85","value":"-0.17"},{"date":"2025.11.27","price":"-0.25","value":"-0.20"},{"date":"2025.11.26","price":"1.02","value":"1.10"},{"date":"2025.11.25","price":"1.53","value":"2.23"},{"date":"2025.11.24","price":"0.37","value":"1.45"},{"date":"2025.11.21","price":"-3.41","value":"-3.83"},{"date":"2025.11.20","price":"-0.76","value":"-0.26"},{"date":"2025.11.19","price":"-0.00","value":"-1.93"},{"date":"2025.11.18","price":"-0.92","value":"-1.16"},{"date":"2025.11.17","price":"-0.11","value":"-1.58"},{"date":"2025.11.14","price":"-1.93","value":"0.97"},{"date":"2025.11.13","price":"1.78","value":"1.58"},{"date":"2025.11.12","price":"-0.36","value":"0.46"},{"date":"2025.11.11","price":"-1.03","value":"0.64"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 海南海药 | 26.33% | -2.86% | 4.7分 |
| 2 | 常山药业 | 24.61% | 0.08% | 5.2分 |
| 3 | 康芝药业 | 24.42% | -10.89% | 3.8分 |
| 4 | 海思科 | 15.15% | 3.20% | 5.9分 |
| 5 | 海创药业 | 15.05% | 14.61% | 5.5分 |
| 6 | 悦康药业 | 14.99% | -0.66% | 5.1分 |
| 8 | 前沿生物 | 10.67% | -1.81% | 4.8分 |
| 10 | 福元医药 | 8.00% | -3.49% | 5.4分 |
| 12 | *ST赛隆 | 6.38% | 2.16% | 5.2分 |
| 14 | 河化股份 | 5.50% | 5.08% | 5.0分 |
| 16 | 京新药业 | 4.11% | -2.51% | 4.1分 |
| 18 | 广济药业 | 3.95% | -14.52% | 4.7分 |
| 20 | 恒瑞医药 | 3.31% | 3.21% | 5.9分 |
| 22 | 普洛药业 | 2.38% | -1.36% | 5.6分 |
| 24 | 圣诺生物 | 2.34% | 1.53% | 5.1分 |
| 26 | 民生健康 | 1.91% | -3.98% | 4.3分 |
| 28 | 苑东生物 | 1.71% | 2.33% | 5.9分 |
| 30 | 健康元 | 1.29% | 0.72% | 5.7分 |
| 32 | ST复华 | 0.69% | 2.11% | 4.2分 |
| 34 | 科伦药业 | 0.37% | -4.59% | 5.0分 |
| 36 | 国邦医药 | -0.38% | -2.63% | 5.7分 |
| 38 | 恩华药业 | -0.45% | 0.95% | 5.4分 |
| 40 | 天新药业 | -1.22% | 3.22% | 5.1分 |
| 42 | 山河药辅 | -1.50% | -3.89% | 3.8分 |
| 44 | ST诺泰 | -1.64% | 1.64% | 4.8分 |
| 46 | 西点药业 | -1.88% | 2.53% | 4.7分 |
| 48 | 华东医药 | -2.02% | -1.90% | 6.0分 |
| 50 | 莎普爱思 | -2.05% | -2.87% | 5.5分 |
| 52 | 卫信康 | -2.13% | -1.87% | 4.8分 |
| 54 | 哈三联 | -2.41% | -0.49% | 4.2分 |
| 56 | 一品红 | -2.60% | -1.16% | 4.1分 |
| 58 | 博瑞医药 | -3.04% | -1.15% | 4.3分 |
| 60 | 润都股份 | -3.30% | -2.81% | 3.9分 |
| 62 | 津药药业 | -3.62% | -2.52% | 4.9分 |
| 64 | 仙琚制药 | -3.73% | 3.70% | 5.1分 |
| 66 | 海森药业 | -3.96% | -1.14% | 4.7分 |
| 68 | 国药现代 | -4.32% | -0.68% | 5.0分 |
| 70 | 华海药业 | -4.34% | 0.34% | 5.3分 |
| 72 | 丽珠集团 | -4.58% | 0.28% | 5.3分 |
| 74 | 赛分科技 | -4.85% | -6.43% | 5.0分 |
| 76 | 同和药业 | -4.97% | -1.35% | 3.8分 |
| 78 | 尔康制药 | -5.19% | -5.68% | 4.1分 |
| 80 | 华润双鹤 | -5.29% | -0.64% | 5.1分 |
| 82 | 亿帆医药 | -5.42% | 2.23% | 5.1分 |
| 84 | 汉商集团 | -5.52% | -2.84% | 4.8分 |
| 86 | 赛托生物 | -5.67% | -2.72% | 3.9分 |
| 88 | 海正药业 | -6.05% | -0.48% | 5.2分 |
| 90 | 多瑞医药 | -6.16% | 8.27% | 5.2分 |
| 92 | 罗欣药业 | -6.33% | -3.36% | 4.3分 |
| 94 | 吉贝尔 | -6.76% | 1.70% | 5.2分 |
| 96 | 宣泰医药 | -6.84% | -1.26% | 3.8分 |
| 98 | 溢多利 | -6.99% | -2.86% | 3.6分 |
| 100 | 金石亚药 | -7.02% | -8.01% | 4.1分 |
| 102 | ST天圣 | -7.18% | -4.00% | 3.9分 |
| 104 | 本立科技 | -7.35% | -1.82% | 4.8分 |
| 106 | 华特达因 | -7.52% | -2.12% | 5.1分 |
| 108 | 北陆药业 | -7.62% | -0.49% | 4.5分 |
| 110 | 复旦张江 | -7.66% | -0.82% | 3.9分 |
| 112 | 力生制药 | -7.85% | -1.61% | 5.0分 |
| 114 | 向日葵 | -8.14% | -2.56% | 4.2分 |
| 116 | 奥赛康 | -8.45% | -1.10% | 5.1分 |
| 118 | 健友股份 | -8.60% | -2.27% | 3.5分 |
| 120 | 键凯科技 | -9.03% | -1.03% | 3.8分 |
| 122 | 立方制药 | -9.35% | -1.86% | 5.3分 |
| 124 | 汇宇制药 | -9.85% | -3.50% | 3.5分 |
| 126 | - | -10.20% | -4.19% | 分 |
| 128 | 纳微科技 | -10.29% | -0.87% | 4.6分 |
| 130 | 小方制药 | -10.39% | -1.78% | 4.8分 |
| 132 | 海辰药业 | -10.74% | -5.14% | 3.5分 |
| 134 | 共同药业 | -10.81% | -2.41% | 4.3分 |
| 136 | 易明医药 | -11.06% | -2.01% | 4.1分 |
| 138 | 广生堂 | -11.47% | -1.18% | 3.8分 |
| 140 | 千红制药 | -12.40% | -1.83% | 3.9分 |
| 142 | - | -13.09% | -3.69% | 分 |
| 144 | 科源制药 | -13.43% | -4.50% | 3.2分 |
| 146 | 灵康药业 | -13.99% | -4.84% | 3.7分 |
| 148 | 亨迪药业 | -14.48% | -7.93% | 3.4分 |
| 150 | 盟科药业 | -15.85% | -0.96% | 3.9分 |
| 152 | - | -16.38% | -4.84% | 分 |
| 154 | - | -17.22% | -4.33% | 分 |
| 156 | 舒泰神 | -23.54% | -1.05% | 3.6分 |
| 158 | 退市苏吴 | -58.33% | -60.78% | 4.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 38/219 ， 55/219。
[{"date":"2025-09-30","value":"7.61","vol":"1.46"},{"date":"2025-06-30","value":"7.02","vol":"1.21"},{"date":"2025-03-31","value":"1.16","vol":"-0.17"},{"date":"2024-12-31","value":"3.82","vol":"19.51"},{"date":"2024-09-30","value":"3.43","vol":"4.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.61 | 7.02 | 1.16 | 3.82 | 3.43 |
| 行业(%) | 1.46 | 1.21 | -0.17 | 19.51 | 4.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"57.82","vol":"49.47"},{"date":"2025-06-30","value":"59.16","vol":"49.43"},{"date":"2025-03-31","value":"58.01","vol":"49.23"},{"date":"2024-12-31","value":"55.07","vol":"50.77"},{"date":"2024-09-30","value":"55.21","vol":"50.51"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
57.82 | 59.16 | 58.01 | 55.07 | 55.21 |
| 行业(%) | 49.47 | 49.43 | 49.23 | 50.77 | 50.51 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 70/219 ， 15/219。
[{"date":"2025-09-30","value":"-1.61","vol":"141.76"},{"date":"2025-06-30","value":"-1.76","vol":"78.53"},{"date":"2025-03-31","value":"1.37","vol":"-0.84"},{"date":"2024-12-31","value":"15.88","vol":"17.76"},{"date":"2024-09-30","value":"12.31","vol":"45.69"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-1.61 | -1.76 | 1.37 | 15.88 | 12.31 |
| 行业(%) | 141.76 | 78.53 | -0.84 | 17.76 | 45.69 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"119.05","vol":"-5.21"},{"date":"2025-06-30","value":"235.04","vol":"56.29"},{"date":"2025-03-31","value":"-6.56","vol":"-21.21"},{"date":"2024-12-31","value":"-49.00","vol":"-20.55"},{"date":"2024-09-30","value":"-50.61","vol":"-32.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
119.05 | 235.04 | -6.56 | -49.00 | -50.61 |
| 行业(%) | -5.21 | 56.29 | -21.21 | -20.55 | -32.33 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 118/219 ， 57/219。
[{"date":"2025-09-30","value":"0.17","vol":"0.31"},{"date":"2025-06-30","value":"0.12","vol":"0.21"},{"date":"2025-03-31","value":"0.06","vol":"0.10"},{"date":"2024-12-31","value":"0.23","vol":"0.43"},{"date":"2024-09-30","value":"0.17","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.17 | 0.12 | 0.06 | 0.23 | 0.17 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.96","vol":"1.95"},{"date":"2025-06-30","value":"1.32","vol":"1.31"},{"date":"2025-03-31","value":"0.69","vol":"0.67"},{"date":"2024-12-31","value":"3.00","vol":"3.22"},{"date":"2024-09-30","value":"2.27","vol":"2.18"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.96 | 1.32 | 0.69 | 3.00 | 2.27 |
| 行业(次) | 1.95 | 1.31 | 0.67 | 3.22 | 2.18 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"19.94","vol":"4.36"},{"date":"2025-06-30","value":"19.58","vol":"2.81"},{"date":"2025-03-31","value":"-0.26","vol":"-28.76"},{"date":"2024-12-31","value":"-1.13","vol":"-371.46"},{"date":"2024-09-30","value":"12.27","vol":"-9.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 19.94 | 19.58 | -0.26 | -1.13 | 12.27 |
| 行业 | 4.36 | 2.81 | -28.76 | -371.46 | -9.87 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.30","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.66","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.30 | - | 0.66 | - |
| 行业 | 0.00 | 1.72 | 0.00 | 1.99 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 115/219 ， 121/219。
[{"date":"2025-09-30","value":"4.62","vol":"3.49"},{"date":"2025-06-30","value":"4.62","vol":"3.67"},{"date":"2025-03-31","value":"4.33","vol":"3.59"},{"date":"2024-12-31","value":"4.10","vol":"3.34"},{"date":"2024-09-30","value":"4.01","vol":"3.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.62 | 4.62 | 4.33 | 4.10 | 4.01 |
| 行业 | 3.49 | 3.67 | 3.59 | 3.34 | 3.66 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"4.00","vol":"2.74"},{"date":"2025-06-30","value":"4.08","vol":"2.89"},{"date":"2025-03-31","value":"3.71","vol":"2.81"},{"date":"2024-12-31","value":"3.54","vol":"2.64"},{"date":"2024-09-30","value":"3.61","vol":"2.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
4.00 | 4.08 | 3.71 | 3.54 | 3.61 |
| 行业 | 2.74 | 2.89 | 2.81 | 2.64 | 2.92 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 116/219 ， 121/219。
[{"date":"2025-09-30","value":"15.50","vol":"33.75"},{"date":"2025-06-30","value":"15.39","vol":"33.79"},{"date":"2025-03-31","value":"16.39","vol":"34.04"},{"date":"2024-12-31","value":"17.03","vol":"34.19"},{"date":"2024-09-30","value":"16.85","vol":"33.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
15.50 | 15.39 | 16.39 | 17.03 | 16.85 |
| 行业(%) | 33.75 | 33.79 | 34.04 | 34.19 | 33.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.18","vol":"0.94"},{"date":"2025-06-30","value":"0.18","vol":"0.88"},{"date":"2025-03-31","value":"0.20","vol":"1.46"},{"date":"2024-12-31","value":"0.21","vol":"0.84"},{"date":"2024-09-30","value":"0.20","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.18 | 0.18 | 0.20 | 0.21 | 0.20 |
| 行业(%) | 0.94 | 0.88 | 1.46 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"1.22","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.94","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.62","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.85","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"4.38","blueLineValue":"1.70","type":"YC"}]